COMP <GO>
ZYBT vs CPIX // EV/EBITDA & P/E VALUATION
Zhengye Biotechnology Holding Limited (Class A) (NASDAQ) VS. Cumberland Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: ZYBT 2
— CPIX 8
■ METRIC PARITY
LAST: $1.34 (+0.75%) • MKT CAP: $63.0M
valuation
—
LAST: $4.31 (+2.13%) • MKT CAP: $63.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZYBT VS. CPIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZYBT | CPIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.50% | 85.00% | -64.50 | CPIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.30% | -16.40% | -5.90 | CPIX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.61% | 7.42% | -4.81 | CPIX | /fcf-yield <GO> |
| Operating Margin | -60.00% | -6.30% | -53.70 | CPIX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -6.40% | -53.60 | CPIX | /net-margins <GO> |
| Revenue Growth (YoY) | -34.80% | 17.60% | -52.40 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.90 | 0.72 | +1.18 | ZYBT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.1 | 32.7 | +12.40 | ZYBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $63.0M | $63.2M | -$198.2K | CPIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZYBT REV | CPIX REV | ZYBT GROSS % | CPIX GROSS % | ZYBT FCF | CPIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.6M | $44.5M | 20.5% | 85.0% | $1.8M | $4.8M |
| FY 2024 | $25.5M | $37.9M | 49.0% | 82.6% | $3.8M | -$678.6K |
| FY 2023 | — | $39.6M | — | — | — | $6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZYBT // BETA —
CPIX // BETA —